Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

phenotyping

- PMLiVE

UK to improve commercial viability of antibiotic research

Government unveils new research incentives as part of antimicrobial resistance strategy

- PMLiVE

UK market access: The importance of a local value story

Meeting the needs of the health service’s new stakeholders

UK flag

UK sets aside £124m for health research projects

National Institute for Health Research to aims to revolutionise care

UK flag

London plans ‘Med City’ to boost UK life sciences sector

£1.1m investment will bring London, Oxford and Cambridge together in 'golden triangle' of research

- PMLiVE

UK appoints chief inspector of adult social care

Andrea Sutcliffe to improve way the CQC regulates social care

- PMLiVE

Interview: David Haslam, NICE

The new chair of the UK’s NICE discusses navigating the stormy waters of health service reforms, collaborating with pharma and the introduction of VBP

UK flag

UK plans to cut some drug prices by up to 20 per cent

DH proposal relates to medicines not covered by PPRS

- PMLiVE

UK phenome lab opens for business

Was previously used by GSK as doping facility during 2012 Olympics

- PMLiVE

NIHR streamlines clinical trials service for pharma

Aims to help speed up studies in the NHS in England

- PMLiVE

Sanofi launches diabetes drug Lyxumia in the UK

Says drug could make multimillion pound savings for the NHS

- PMLiVE

Union calls on AstraZeneca to reconsider Alderley Park plans

Unite says move to Cambridge will take years to deliver value

ABPI London offices

ABPI: Pharma must sell outcomes, not products

Annual conference told industry must re-establish its social contract with the NHS

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links